Bioequivalence of a Highly Variable Drug: An Experience with Nadolol

Pharmacokinetics of Nadolol, a Beta‐Receptor Antagonist: Administration of Therapeutic Single‐ and Multiple‐Dosage Regimens to Hypertensive Patients

Jacques Dreyfuss, D. L. Griffith, S. M. Singhvi et al. · The Journal of Clinical Pharmacology · 1979 · 50 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Effect of beta‐blockers on exercise double product (systolic blood pressure x heart rate).

R. A. Vukovich, JE Foley, B. Greg Brown et al. · British Journal of Clinical Pharmacology · 1979 · 37 citations · Full text

Medicine, Cardiology, Pharmacology +16

Elimination of nadolol by patients with renal impairment.

J Herrera, R. A. Vukovich, D. L. Griffith · British Journal of Clinical Pharmacology · 1979 · 36 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Effects of nadolol on hemodynamic and hemostatic responses to potential mental and physical triggers of myocardial infarction in subjects with mild systemic hypertension

Alfredo H. Jimenez, Geoffrey H. Tofler, Xianghong Chen et al. · The American Journal of Cardiology · 1993 · 34 citations

Medicine, Cardiology, Pharmacology +14

Effect of exercise and of prolonged oral administration of propranolol on haemodynamic variables, plasma renin concentration, plasma aldosterone and c‐AMP

J Bonelli, W. Waldhäusl, D Magometschnigg et al. · European Journal of Clinical Investigation · 1977 · 23 citations

Life Sciences, Pharmacology, Physiology +16